Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Anika Therapeutics (ANIK) Debt Ratio (2020 - 2022)

Anika Therapeutics (ANIK) has disclosed Debt Ratio for 7 consecutive years, with 0.01 as the latest value for Q2 2022.

  • On a quarterly basis, Debt Ratio fell 73.77% to 0.01 in Q2 2022 year-over-year; TTM through Jun 2022 was 0.01, a 73.77% decrease, with the full-year FY2021 number at 0.01, down 65.32% from a year prior.
  • Debt Ratio was 0.01 for Q2 2022 at Anika Therapeutics, down from 0.01 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.11 in Q2 2020 to a low of 0.01 in Q3 2021.
  • A 3-year average of 0.04 and a median of 0.04 in 2020 define the central range for Debt Ratio.
  • Peak YoY movement for Debt Ratio: tumbled 59.07% in 2021, then plummeted 81.67% in 2022.
  • Anika Therapeutics' Debt Ratio stood at 0.04 in 2020, then tumbled by 65.32% to 0.01 in 2021, then dropped by 1.86% to 0.01 in 2022.
  • Per Business Quant, the three most recent readings for ANIK's Debt Ratio are 0.01 (Q2 2022), 0.01 (Q1 2022), and 0.01 (Q4 2021).